Why do Cox-2 Selective increase clots? (possible NBME 7 spoiler)

This forum made possible through the generous support of SDN members, donors, and sponsors. Thank you.

ej37

Full Member
10+ Year Member
15+ Year Member
Joined
Jul 2, 2008
Messages
272
Reaction score
1
There was an NBME 7 question about why cox 2 increases clot risk... I got the question wrong. I can't seem to find a conclusive answer in any review text, but searching through some stuff online leads me to believe that its because COX-2 block doesn't block TXA as much. Is there a reason for this? I.e. is there a concept here or is this just a fact I need to memorize? I would appreciate any insight you might have. By the way, what WAS the right answer to that NBME 7 question?
 
let's see...So, COX-2 is constitutively expressed in certain tissues, most importantly in the endothelial cells (and the kidneys). Platelets have COX-1. So coxibs inhibit endothelial production of prostacyclin, which is anti-thrombotic. The platelet's production of thromboxane A2 is left untouched--thus the balance is tilted in favor of clotting.
 
let's see...So, COX-2 is constitutively expressed in certain tissues, most importantly in the endothelial cells (and the kidneys). Platelets have COX-1. So coxibs inhibit endothelial production of prostacyclin, which is anti-thrombotic. The platelet's production of thromboxane A2 is left untouched--thus the balance is tilted in favor of clotting.

Damnn...that's crazy. Don't ever remember reading about this distinction at this level of detail (COX 2 -> endothelial cells) and (COX 1-> platelets). FA has a thrombogenesis diagram and just lists "COX" for the conversion to TxA2.
 
Last edited:
Top